Single-use end-to-end solutions - flexible, scalable and reliable

micheal-eder

Michael Eder

June 2, 2021

Table of contents

Show

In an extremely complex, competitive and constantly evolving sector such as the biopharmaceutical industry, flexibility is key, not least since it is an immensely varied and compliance-driven field.

This is one of the reasons why more and more logistics solutions - covering all steps from filling to freezing, thawing and distribution - are primarily based on single-use technologies. They allow for the greatest flexibility and agility and can be adapted to lab and production-site environments in equal measure.

Thanks to their versatility, they are set to gain ever more importance and traction in the competitive race to develop new products or manufacture tried-and-tested compounds and bring them to the market respectively to the patient.

Thanks to their modular design and set-up, single-use systems can be adapted and scaled to meet specific manufacturer or lab needs, which sets them apart from standalone “silo” platforms. They facilitate safe and reliable, bespoke, logistics processes for highly valuable and sensitive drug substances, while at the same time offering the highest degree of flexibility.

Simplification is key - optimizing performance and efficiency with single-use technologies

Simplification is key - especially when it comes to complex areas such as the development and production of medical drug substances. Based on the idea of maximum elasticity, Single Use Support have reinterpreted basic production and logistics processes to offer flexible and agile solutions such as modular freeze thaw platforms to players in the biopharma industry.

With their products, they aim to simplify elaborate processes, thus making life easier for manufacturers and service providers. All processes are dismantled into single steps, which can then be strung together as per requirement to deliver a bespoke functional solution that covers every single step from beginning to end, without subjecting the substances to any form of contamination risk.

All Single Use Support platforms are:

  • compatible with both single-use bags and bottles 
  • scalable for volumes from a few milliliters to several hundreds of liters
  • adaptable thanks to their modular design and set-up
  • reliable - offering a monitored and controlled process from beginning to end

eBook: Filling Gaps in Managing Large Volumes of Biologics

Aseptic aliquotation and cryopreservation of drug substances are crucial process steps in bioprocessing. Even though they’re not in the spotlight of biomanufacturing. In drug development and drug delivery, biologics must be transferred at numerous occasions. Along the journey of monoclonal antibodies, vaccines and more, the drug substance passes lots of process steps where liquid transfer is required. This is relevant for the transitions between upstream processing, downstream processing and fill & finish, but also within these manufacturing milestones. The market of fluid & cold chain management has great growth potential and is on its way to professionalization and industrialization. To meet the challenges of manufacturing drug substances, Single Use Support helps manufacturers and CDMOs to advance their fluid & cold chain management process to achieve a secure and efficient process for liquids on the basis of single-use bags.

One platform serving every need - usable with bags and bottles

RoSS is a sophisticated end-to-end freeze thaw platform that is composed of single-use components, thus facilitating a comprehensive and elaborate logistics approach. It provides for reliable and safe freezing and shipping of both single-use bags and bottles filled with your precious content. Its single-use architecture rules out risks of incompatibility while at the same time minimizing potential product loss or other damages caused by human error. 

In line with the definition of end-to-end and its inherent single-use architecture, RoSS is a flexible and scalable freeze thaw platform that can be adapted as needed, be it by adding a number of optional components such as filtration systems or by scaling up/down to larger/smaller volumes and batches. And while it is ultimately designed to be used with single-use bags of any brand or size, it can be combined with bottles commonly available on the market.

One platform for bags & bottles

One automation software - transferable to all scales

As is the case with all of Single Use Support’s technologies, RoSS is a scalable platform that fits into existing environments for different areas of application. It is designed to handle any volume of high-value liquid drug substances in a variety of primary packaging that will be protected by the RoSS shell, which is a container made of stainless-steel and foam to offer maximum protection of your precious goods.

Thanks to the integrated automation software, the platform is transferable to all scales. While you may be starting out with small batches, you may well need to upscale to meet the need on the market once your product has been approved.

All available technologies are elaborate modular platforms on the basis of a closed system. They cover everything from filling and filtration to the freeze/thaw process and shipping. At a glance, the following options are available: 

  • RoSS Fill: 1 CU with an option of different racks available
  • RoSS pFTU: 1 automation software that is transferable to all scales
  • RoSS FRIG/SHIP: compatible with single-use bags and bottles

It goes without saying that every single process step is performed in a fully automated manner in order to allow for the highest degrees of accuracy and simplicity.

In addition, this allows customers to reduce human error to a minimum thanks to its controllable automatic design and with the substances being protected throughout their journey. While there is a trend towards utilizing single-use bags as primary packaging, Single Use Support’s platforms are compatible and can be combined with bottles commonly available on the market - like this you remain bag supplier independent.

And you - quite literally - can take your production to the next level - all thanks to an intelligent software that is transferable to all scales, from lab to blockbuster production.

One automatation in all scales
micheal-eder

Michael Eder

Senior Marketing Manager

Michael Eder, MA, is Senior Marketing Manager at Single Use Support. He is expert in pharma and health communication with his 10+ years experience in pharma. After completing his master's degree in International Healthcare Management at MCI The Entrepreneurial school in Innsbruck, he has gained experience in the pharmaceutical field manufacturing and commercialization of OTC and RX drugs. Michael creates articles about Freeze Thaw applications and Platform solutions from Single Use Support and is the author of current news with Single Use Support worldwide. 

More from Michael Eder

News

Single Use Support honoured as one of the ‘Best Managed Companies’

Deloitte Austria and Raiffeisenlandesbank Niederösterreich-Wien have honoured outstandingly managed companies. Single Use Support was the only winner from Tyrol to be honoured with the title ‘Best Managed Company 2024’. 

micheal-eder

Michael Eder

September 30, 2024

News

Third consecutive Pharma Innovation Award for Single Use Support

RoSS.PADL, the homogenizing solution from Single Use Support, was awarded the 2024 Innovation Award by Pharma Manufacturing.

micheal-eder

Michael Eder

September 26, 2024

Read more about Biopharma

Biopharma

Annex 1: All you need to know

Annex 1 is a fundamental framework for the production of sterile medicinal goods. This article will provide an overview of the concept, its history, contents, challenges, and perspectives.

michael-muehlegger

Michael Mühlegger

March 20, 2024

Biopharma

Top 7 pharmaceutical CDMOs in 2024

Progress in the pharmaceutical industry is significantly driven by CDMOs, collaborating with pharma companies. In this article, we will put 7 outstanding CDMOs in the spotlight.

michael-muehlegger

Michael Mühlegger

March 12, 2024

Biopharma

CMO vs. CDMO: What are the differences?

Both CMOs and CDMOs are frequently relied on partners in the pharmaceutical industry. But what sets them apart, where are their strengths, and what do they offer?

michael-muehlegger

Michael Mühlegger

March 12, 2024

Biopharma

Start Pharma 4.0: Examples to Advance Ultra-Cold Storage of Drug Substances

Innovative manufacturers are striving for operational excellence in as many areas of bioprocessing as possible. In return,a standardized and fully automated processes contribute to cost efficiency, patient safety, and sustainability in biomanufacturing. 

Alexander Fuchs | Single Use Support

Alexander Fuchs

September 4, 2023